Skip to main content
logo
Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
400.43
+4.11 (1.04%)
At close: Nov 4, 2026, 4:00 PM EST
395.01
-5.42 (-1.35%)
Pre-market: Nov 5, 2026, 7:47 AM EST

Madrigal Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,428958.4180.13---
Revenue Growth
92.80%432.05%----
Gross Profit
1,299902.26173.9---
Operating Income
-152.65-300.1-497.88-380.5-293.57-242.48
Net Income
-155.46-288.28-465.89-373.63-295.35-241.85
Earnings Per Share
-6.73-12.85-21.90-19.99-17.23-14.63
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
960.97983.56926.25634.13358.77270.35
Total Debt
354.22347.63119.57117.1949.890.8
Net Cash (Debt)
606.75635.93806.68516.94308.88269.55
Net Cash Growth
-20.52%-21.17%56.05%67.36%14.59%-4.88%
Net Cash Per Share
26.2828.3537.9227.6618.0216.30

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-157.01-189.55-455.57-324.23-224.86-183.92
Capital Expenditures
-11.64-0.47-1.46-1.48-0.22-0.21
Free Cash Flow
-168.65-190.02-457.03-325.71-225.07-184.13
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
90.96%94.14%96.54%---
Operating Margin
-10.69%-31.31%-276.39%---
Pretax Margin
-10.89%-30.08%-258.64%---
Profit Margin
-10.89%-30.08%-258.64%---
FCF Margin
-11.81%-19.83%-253.72%---

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
106.38191.16----
PS Ratio
6.5113.8037.36---